These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18957265)

  • 1. Differential role of the transcription factor NF-kappaB in selection and survival of CD4+ and CD8+ thymocytes.
    Jimi E; Strickland I; Voll RE; Long M; Ghosh S
    Immunity; 2008 Oct; 29(4):523-37. PubMed ID: 18957265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
    Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
    J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lack of NF-kappa B transactivation and PKC epsilon expression in CD4(+)CD8(+) thymocytes correlates with negative selection.
    Simon AK; Auphan N; Pophillat M; Boyer C; Ghosh S; Rincón M; Flavell RA; Schmitt-Verhulst AM
    Cell Death Differ; 2000 Dec; 7(12):1253-62. PubMed ID: 11175263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of the major compatibility complex-dependent development of CD4+ and CD8+ T cells by the Cbl family proteins.
    Huang F; Kitaura Y; Jang I; Naramura M; Kole HH; Liu L; Qin H; Schlissel MS; Gu H
    Immunity; 2006 Oct; 25(4):571-81. PubMed ID: 17045823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.
    Jones RG; Parsons M; Bonnard M; Chan VS; Yeh WC; Woodgett JR; Ohashi PS
    J Exp Med; 2000 May; 191(10):1721-34. PubMed ID: 10811865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential requirement of IKK2 for CYLD-dependent representation of thymic and peripheral T-cell populations.
    Tsagaratou A; Grammenoudi S; Mosialos G
    Eur J Immunol; 2011 Oct; 41(10):3054-62. PubMed ID: 21728169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes "paradoxically" appear as CD4+8lo transitional cells during positive selection of CD8+ T cells.
    Bosselut R; Guinter TI; Sharrow SO; Singer A
    J Exp Med; 2003 Jun; 197(12):1709-19. PubMed ID: 12810689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage.
    Paterson RK; Burkly LC; Kurahara DK; Dunlap A; Flavell RA; Finkel TH
    J Immunol; 1994 Oct; 153(8):3491-503. PubMed ID: 7930572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limiting TCR expression leads to quantitative but not qualitative changes in thymic selection.
    Dave VP; Allman D; Wiest DL; Kappes DJ
    J Immunol; 1999 May; 162(10):5764-74. PubMed ID: 10229809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength.
    Izon DJ; Punt JA; Xu L; Karnell FG; Allman D; Myung PS; Boerth NJ; Pui JC; Koretzky GA; Pear WS
    Immunity; 2001 Mar; 14(3):253-64. PubMed ID: 11290335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage-dependent reactivity of thymocytes to self-peptide--MHC complexes.
    Leng Q; Ge Q; Nguyen T; Eisen HN; Chen J
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5038-43. PubMed ID: 17360333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How many thymocytes audition for selection?
    Merkenschlager M; Graf D; Lovatt M; Bommhardt U; Zamoyska R; Fisher AG
    J Exp Med; 1997 Oct; 186(7):1149-58. PubMed ID: 9314563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal thymic selection of TCR transgenic CD4 T cells, but impaired survival in the periphery despite the presence of selecting MHC molecules.
    Barthlott T; Wright RJ; Stockinger B
    J Immunol; 1998 Oct; 161(8):3992-9. PubMed ID: 9780168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function.
    Zheng Y; Vig M; Lyons J; Van Parijs L; Beg AA
    J Exp Med; 2003 Apr; 197(7):861-74. PubMed ID: 12668645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappa B is required for the positive selection of CD8+ thymocytes.
    Hettmann T; Leiden JM
    J Immunol; 2000 Nov; 165(9):5004-10. PubMed ID: 11046028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and cellular distribution of the rat interleukin-2 receptor beta chain: induction of the IL-2R alpha- beta+ phenotype by major histocompatibility complex class I recognition during T cell development in vivo and by T cell receptor stimulation of CD4+8+ immature thymocytes in vitro.
    Park JH; Hanke T; Hünig T
    Eur J Immunol; 1996 Oct; 26(10):2371-5. PubMed ID: 8898947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF activation of NF-κB is essential for development of single-positive thymocytes.
    Webb LV; Ley SC; Seddon B
    J Exp Med; 2016 Jul; 213(8):1399-407. PubMed ID: 27432943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class II molecules are required for initiation of positive selection but not during terminal differentiation of human CD4 single positive thymocytes.
    Vanhecke D; Verhasselt B; De Smedt M; De Paepe B; Leclercq G; Plum J; Vandekerckhove B
    J Immunol; 1997 Apr; 158(8):3730-7. PubMed ID: 9103437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.